 NEW YORK and VIENNA, Austria, Nov. 07, 2022 GLOBE NEWSWIRE -- HOOKIPA Pharma Inc. NASDAQ: HOOK, HOOKIPA, a company developing a new class of immunotherapies based on its proprietary arenavirus platform, today announced it will release its third quarter 2022 financial results and Company update before the market opens on Monday, November 14, 2022. 